Tranexamic Acid

• 

  Subject Areas on Research

  • A Randomized Controlled Trial of Low-Dose Tranexamic Acid versus Placebo to Reduce Red Blood Cell Transfusion During Complex Multilevel Spine Fusion Surgery. 
  • A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial). 
  • AANA Journal Course: Update for Nurse Anesthetists-Part 5-Use of Tranexamic Acid in Preventing Postpartum Hemorrhage. 
  • Antifibrinolytic Therapy and Perioperative Considerations. 
  • Antifibrinolytic therapy: new data and new concepts. 
  • Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery. 
  • Aprotinin versus tranexamic acid: the controversy continues. 
  • Association between CK-MB Area Under the Curve and Tranexamic Acid Utilization in Patients Undergoing Coronary Artery Bypass Surgery. 
  • Bleeding and management of coagulopathy. 
  • Blood Management in Outpatient Total Hip Arthroplasty. 
  • Blood-Conservation Strategies in a Blood-Refusal Parturient with Placenta Previa and Placenta Percreta. 
  • Clinical Impact of Routine Complete Blood Counts Following Total Knee Arthroplasty. 
  • Comparative analysis of antifibrinolytic medications in pediatric heart surgery. 
  • Coronary artery bypass grafting after aprotinin: are we doing better? 
  • Definite hereditary hemorrhagic telangiectasia in a 60-year-old black Kenyan woman: a case report. 
  • Effect of Antifibrinolytic Therapy on Complications, Thromboembolic Events, Blood Product Utilization, and Fusion in Adult Spinal Deformity Surgery. 
  • Effect of two doses of tranexamic acid on fibrinolysis evaluated by thromboelastography during cardiac surgery: a randomised, controlled study. 
  • Epsilon Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Hip and Total Knee Arthroplasty. 
  • Hemostatic agents and their safety. 
  • Hemostatic agents. 
  • Incidence of Postreperfusion Hyperfibrinolysis in Liver Transplantation by Donor Type and Observed Treatment Strategies. 
  • Intravenous and Topical Tranexamic Acid Alone Are Superior to Tourniquet Use for Primary Total Knee Arthroplasty: A Prospective, Randomized Controlled Trial. 
  • Intravenous tranexamic acid vs. topical thrombin in total shoulder arthroplasty: a comparative study. 
  • Ischemic Preconditioning and the Role of Antifibrinolytic Drugs: Translation From Bench to Bedside. 
  • Laryngeal Edema in a Child with Hereditary Angioedema with Normal C1 Inhibitor. 
  • National trends in tranexamic acid use in the peripartum period, 2015-2019. 
  • Nonsurgical management of heavy menstrual bleeding: a systematic review. 
  • Optimal Tranexamic Acid Dosing Regimen in Cardiac Surgery: What Are the Missing Pieces? 
  • Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women. 
  • Pharmacologic methods to reduce perioperative bleeding. 
  • Population pharmacokinetics and pharmacodynamics of Tranexamic acid in women undergoing caesarean delivery. 
  • Postpartum hemorrhage management in 2012: predicting the future. 
  • Preoperative Hemoglobin Predicts Postoperative Transfusion Despite Antifibrinolytics During Total Knee Arthroplasty. 
  • Preventing postpartum hemorrhage with combined therapy rather than oxytocin alone. 
  • Refractory status epilepticus after inadvertent intrathecal injection of tranexamic acid treated by magnesium sulfate. 
  • Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers. 
  • Rotational thromboelastometry-guided transfusion during lumbar pedicle subtraction osteotomy for adult spinal deformity: preliminary findings from a matched cohort study. 
  • Safety of antifibrinolytics in 6583 pediatric patients having craniosynostosis surgery: A decade of data reported from the multicenter Pediatric Craniofacial Collaborative Group. 
  • Safety of antifibrinolytics in cranial vault reconstructive surgery: a report from the pediatric craniofacial collaborative group. 
  • The Immunologic Effect of Early Intravenous Two and Four Gram Bolus Dosing of Tranexamic Acid Compared to Placebo in Patients With Severe Traumatic Bleeding (TAMPITI): A Randomized, Double-Blind, Placebo-Controlled, Single-Center Trial. 
  • The risk of thromboembolic events with early intravenous 2- and 4-g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double-blind, placebo-controlled, single-center trial. 
  • Tranexamic Acid for Acute Hemorrhage: When Is Enough Evidence Enough? 
  • Tranexamic Acid for Prevention and Treatment of Postpartum Hemorrhage: An Update on Management and Clinical Outcomes. 
  • Tranexamic acid administration practice in otolaryngology head & neck surgery; international survey. 
  • Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial. 
  • Update on massive transfusion. 
  • Using antifibrinolytics in the peripartum period - concern for a hypercoagulable effect? 
  • Von Willebrand factor for menorrhagia: a survey and literature review. 
  • What Should Define Preoperative Anemia in Primary THA? 
  • When Should Complete Blood Count Tests Be Performed in Primary Total Hip Arthroplasty Patients? 
  • [Efficacy and safety of tranexamic acid administration for the prevention and/or the treatment of post-partum haemorrhage: a systematic review with meta-analysis]. 
  • eComment: Treating endoleak type 2 and disseminated intravascular coagulopathy after EVAR with tranexamic acid: the efficacy of killing two birds with one stone. 
  • ε-Aminocaproic acid and clinical value in cardiac anesthesia. 
• 

  Keywords of People

  • Levy, Jerrold Henry, Professor of Anesthesiology, Anesthesiology, Cardiothoracic